TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
FTRE

Fortrea Holdings Inc.

Healthcare · Biotechnology

19.90$ -1.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement FTRE
Line item 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
81.0% 80.2% 74.5% 79.2% 80.2% 84.4%
19.0% 19.8% 25.5% 20.8% 19.8% 15.6%
10.4% 9.9% 10.6% 11.8% 20.8% 16.8%
31.1% 16.0% 18.9% 19.7% 25.8% 16.8%
-12.2% 3.7% 6.6% 1.1% -6.0% -1.1%
0.0% 0.0% 2.5% 4.6% 3.4%
-12.9% 4.5% 6.6% -1.1% -10.2% -36.1%
1.0% 1.3% 1.4% 0.0% -0.1% 0.1%
-13.9% 3.2% 6.6% -0.9% -12.2% -36.2%
8.6% 9.9% 9.9% 4.8% -2.4% -29.9%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?